Charles Sermon's Net Worth

$955 Thousand

Estimate Recalculated Sep 16, 2024 07:51PM EST

Who is Charles Sermon?

Charles Sermon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Mereo BioPharma Group plc, and ALBIREO PHARMA, INC..

SEC CIK

Charles Sermon's CIK is 0001687318

Past Insider Trading and Trends

2024 was Charles Sermon's most active year for acquiring shares with 3 total transactions. Charles Sermon's most active month to acquire stocks was the month of May. 2024 was Charles Sermon's most active year for disposing of shares, totalling 2 transactions. Charles Sermon's most active month to dispose stocks was the month of May. 2024 saw Charles Sermon paying a total of $0.00 for 441,800 shares, this is the most they've acquired in one year. In 2024 Charles Sermon cashed out on 46,389 shares for a total of $161,677.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mereo BioPharma Group plc (MREO) Snapshot price: $4.3

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.37%
-30.93K
$4.30
-$133,050.61
219.06K
Sep 12 - Sep 13
Form 4
+35.58%
65.6K
—
—
249.99K
Sep 11
Form 4
-20.10%
-46.39K
$3.49
-$161,677.70
184.39K
Jun 25 - Jun 26
Form 4
+74.33%
98.4K
—
—
230.78K
Jun 21
Form 4
—
0
—
—
0
Jan 25
Form 3
—
0
—
—
0
No matching records found

ALBIREO PHARMA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found